Journal profile
ADVANCES IN ENZYMOLOGY AND RELATED SUBJECTS
ISSN 0065-258X · eISSN 1934-4694 · Irregular
ADVANCES IN ENZYMOLOGY AND RELATED SUBJECTS: subscription journal; community-reported acceptance: easy.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, ADVANCES IN ENZYMOLOGY AND RELATED SUBJECTS's largest topics are Porphyrin Metabolism and Disorders, Biochemical and Molecular Research and Photosynthetic Processes and Mechanisms, together about 30.8% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Advances in Enzymology and Related Areas of Molecular Biology is one of the seminal series in the area of biochemistry. Giving the practising scientist access to regular and authoritative review of the latest advances in the rapidly moving area of enzymology and its role in molecular biology, the series is an essential information source for both students and researchers alike.
From the journal's Aims & Scope
Main research topics OpenAlex counts of recent articles; shares are approximate
- Porphyrin Metabolism and DisordersBiochemistry, Genetics and Molecular Biology11.6%
- Biochemical and Molecular ResearchBiochemistry, Genetics and Molecular Biology9.6%
- Photosynthetic Processes and MechanismsBiochemistry, Genetics and Molecular Biology9.6%
- Enzyme Structure and FunctionMaterials Science8.8%
- Enzyme function and inhibitionBiochemistry, Genetics and Molecular Biology7.8%
- Protein Structure and DynamicsBiochemistry, Genetics and Molecular Biology7.2%
- Enzyme Catalysis and ImmobilizationBiochemistry, Genetics and Molecular Biology5%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 110OpenAlex ·
- i10-index
- 537OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Frequency
- Irregular
- ISSN
- 0065-258X
- Electronic ISSN
- 1934-4694
- Official links
- Journal homepage ↗LetPub
FAQ
Frequently asked questions about ADVANCES IN ENZYMOLOGY AND RELATED SUBJECTS
Is ADVANCES IN ENZYMOLOGY AND RELATED SUBJECTS open access, and what is the APC?
ADVANCES IN ENZYMOLOGY AND RELATED SUBJECTS is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .